Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Krisztina
Krisztina Erdelyi-Brooks, Berkshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20100068397 | LOW VOC COATING COMPOSITION - A pigmented, aqueous coating composition comprising i) an aqueous dispersion of non-crosslinkable addition oligomer of weight average molecular weight of from 5000 to 15000 Daltons and calculated Fox Tg greater than 0° C. and less than 50° C. ii) an aqueous dispersion of addition polymer of weight average molecular weight greater than 53,000 Daltons, calculated Fox Tg greater than 10° C. and less than 40° C. and mean particle diameter of less than 150 nanometers, where the ratio of i):ii) is from 0.25:1 to 2.70:1, based on % weight dispersion solids. | 03-18-2010 |
Krisztina Krempels, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20100076008 | Pharmaceutical compositions containing plasma protein - The invention is related to water-soluble products and pharmaceutical formulations in solid or liquid form mainly for parenteral use. They consist of or comprise a therapeutically active substance (having low aqueous solubility and a substantial binding affinity to plasma proteins) and a plasma protein fraction in controlled aggregation state, whereby the said active substance and the said protein fraction are bound to each other by way of non-covalent bonds. It also covers processes for the preparation of the product and pharmaceutical formulation by dissolving the water-insoluble active substance in a water-miscible, pharmaceutically acceptable solvent, combining said solution with the aqueous solution of a plasma protein fraction in controlled aggregation state whereby a true solution is obtained containing the said active substance and the said protein fraction bound together by way of non-covalent bonds. Optionally a further pharmaceutically acceptable auxiliary additive—such as a protein aggregation controller and/or a stabilizer—may be present. The organic solvent is eliminated by dialysing, ultrafiltrating, diafiltrating and/or lyophilising. The solid products consisting of the active substance and the protein are also protected. On optional dissolution in water clear, liquid compositions are obtained suitable for direct parenteral or other administration. Method of treatment is also covered. A series of water-insoluble substances is enlisted with appropriate protein fractions to be used. | 03-25-2010 |
Krisztina Ludanyi, Telki HU
| Patent application number | Description | Published |
|---|---|---|
| 20090253712 | AQUEOUS SOLVENT SYSTEM FOR SOLUBILIZATION OF AZOLE COMPOUNDS - A pharmaceutical composition includes: | 10-08-2009 |
Krisztina Moricz, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090233913 | OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS - The present invention relates to dihydro-2,3-benzodiazepine compounds of high enantiomeric purity according to the general formula (I), which contain an asymmetric centre at the position 4 of the dihydro-2,3-benzodiazepine compound, and the preparation thereof and the used intermediates as well. These compounds have anti-convulsiveA muscle relaxant and neuroprotective effect due their non-competitive AMPA antagonistic properties. | 09-17-2009 |
| 20090281137 | INDOL-2-ONE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS DISORDERS, GASTROINTESTINAL DISORDERS AND CARDIOVASCULAR DISORDERS - The present invention is related to new 3,3-disubstituted indol-2-one derivatives of the general Formula (I) | 11-12-2009 |
| 20090306144 | PYRIDINE DERIVATIVES OF ALKYL OXINDOLES AS 5-HT7 RECEPTOR ACTIVE AGENTS - New 3,3-disubstituted indol-2-one derivatives of the general formula (I) | 12-10-2009 |
| 20100075975 | MEDICAMENT FOR THE ENHANCEMENT OF COGNITIVE FUNCTION AND NEUROPROTECTION - The invention relates the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H) pyridazinone of the Formula (I) | 03-25-2010 |
Krisztina Móricz, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090281137 | INDOL-2-ONE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS DISORDERS, GASTROINTESTINAL DISORDERS AND CARDIOVASCULAR DISORDERS - The present invention is related to new 3,3-disubstituted indol-2-one derivatives of the general Formula (I) | 11-12-2009 |
| 20090306144 | PYRIDINE DERIVATIVES OF ALKYL OXINDOLES AS 5-HT7 RECEPTOR ACTIVE AGENTS - New 3,3-disubstituted indol-2-one derivatives of the general formula (I) | 12-10-2009 |
Krisztina SoltÈsz, Lübeck DE
| Patent application number | Description | Published |
|---|---|---|
| 20090320850 | RESPIRATION SYSTEM - A respiration system ( | 12-31-2009 |
Krisztina SoltÈsz, Lübeck DE
| Patent application number | Description | Published |
|---|---|---|
| 20090320850 | RESPIRATION SYSTEM - A respiration system ( | 12-31-2009 |
Krisztina Temesvari, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090216009 | PROCESS FOR THE PRODUCTION OF EZETIMIBE AND INTERMEDIATES USED IN THIS PROCESS - An industrially easily realizable and economical process comprising only few steps, and built on new intermediates for the production of 1-(4-3(R)-[3(S)-(4-fluorophenyl)-3-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone (ezetimibe) according to the reaction scheme described herein. | 08-27-2009 |
Krisztina Vukics, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090216009 | PROCESS FOR THE PRODUCTION OF EZETIMIBE AND INTERMEDIATES USED IN THIS PROCESS - An industrially easily realizable and economical process comprising only few steps, and built on new intermediates for the production of 1-(4-3(R)-[3(S)-(4-fluorophenyl)-3-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone (ezetimibe) according to the reaction scheme described herein. | 08-27-2009 |